File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1080/21688370.2021.1879719
- Scopus: eid_2-s2.0-85110900198
- WOS: WOS:000674797800001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD
Title | Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD |
---|---|
Authors | |
Keywords | GI tract barriers GI tract microbiota intestinal permeability microbial metabolites NAFLD |
Issue Date | 19-Jul-2021 |
Publisher | Taylor and Francis Group |
Citation | Tissue Barriers, 2021, v. 9, n. 3 How to Cite? |
Abstract | The Gastrointestinal (GI) tract is composed of four main barriers: microbiological, chemical, physical and immunological. These barriers play important roles in maintaining GI tract homeostasis. In the crosstalk between these barriers, microbiota and related metabolites have been shown to influence GI tract barrier integrity, and alterations of the gut microbiome might lead to an increase in intestinal permeability. As a consequence, translocation of bacteria and their products into the circulatory system increases, reaching proximal and distal tissues, such as the liver. One of the most prevalent chronic liver diseases, Nonalcoholic Fatty Liver Disease (NAFLD), has been associated with an altered gut microbiota and barrier integrity. However, the causal link between them has not been fully elucidated yet. In this review, we aim to highlight relevant bacterial taxa and their related metabolites affecting the GI tract barriers in the context of NAFLD, discussing their implications in gut homeostasis and in disease. |
Persistent Identifier | http://hdl.handle.net/10722/340257 |
ISSN | 2023 SCImago Journal Rankings: 0.978 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fernandez-Cantos, MV | - |
dc.contributor.author | Garcia-Morena, D | - |
dc.contributor.author | Iannone, V | - |
dc.contributor.author | El-Nezami, H | - |
dc.contributor.author | Kolehmainen, M | - |
dc.contributor.author | Kuipers, OP | - |
dc.date.accessioned | 2024-03-11T10:42:50Z | - |
dc.date.available | 2024-03-11T10:42:50Z | - |
dc.date.issued | 2021-07-19 | - |
dc.identifier.citation | Tissue Barriers, 2021, v. 9, n. 3 | - |
dc.identifier.issn | 2168-8362 | - |
dc.identifier.uri | http://hdl.handle.net/10722/340257 | - |
dc.description.abstract | <p>The Gastrointestinal (GI) tract is composed of four main barriers: microbiological, chemical, physical and immunological. These barriers play important roles in maintaining GI tract homeostasis. In the crosstalk between these barriers, microbiota and related metabolites have been shown to influence GI tract barrier integrity, and alterations of the gut microbiome might lead to an increase in intestinal permeability. As a consequence, translocation of bacteria and their products into the circulatory system increases, reaching proximal and distal tissues, such as the liver. One of the most prevalent chronic liver diseases, Nonalcoholic Fatty Liver Disease (NAFLD), has been associated with an altered gut microbiota and barrier integrity. However, the causal link between them has not been fully elucidated yet. In this review, we aim to highlight relevant bacterial taxa and their related metabolites affecting the GI tract barriers in the context of NAFLD, discussing their implications in gut homeostasis and in disease.<br></p> | - |
dc.language | eng | - |
dc.publisher | Taylor and Francis Group | - |
dc.relation.ispartof | Tissue Barriers | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | GI tract barriers | - |
dc.subject | GI tract microbiota | - |
dc.subject | intestinal permeability | - |
dc.subject | microbial metabolites | - |
dc.subject | NAFLD | - |
dc.title | Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD | - |
dc.type | Article | - |
dc.identifier.doi | 10.1080/21688370.2021.1879719 | - |
dc.identifier.scopus | eid_2-s2.0-85110900198 | - |
dc.identifier.volume | 9 | - |
dc.identifier.issue | 3 | - |
dc.identifier.eissn | 2168-8370 | - |
dc.identifier.isi | WOS:000674797800001 | - |
dc.identifier.issnl | 2168-8370 | - |